本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Artiva Biotherapeutics, Inc.

7.49
+0.31004.32%
盤後7.490.00000.00%19:18 EDT
成交量:23.02萬
成交額:174.39萬
市值:1.85億
市盈率:-2.18
高:7.94
開:7.25
低:7.10
收:7.18
52周最高:7.94
52周最低:1.47
股本:2,471.67萬
流通股本:538.17萬
量比:1.40
換手率:4.28%
股息:- -
股息率:- -
每股收益(TTM):-3.4309
每股收益(LYR):-3.4309
淨資產收益率:-56.55%
總資產收益率:-32.97%
市淨率:1.68
市盈率(LYR):-2.18

資料載入中...

2025/03/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/24

重要事件披露

Form 8-K - Current report
2025/01/29

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/22

重要事件披露

Form 8-K - Current report
2024/09/03

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/29

重要事件披露

Form 8-K - Current report
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/01

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/29

超過5%披露

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
2024/07/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/07/22

重要事件披露

Form 8-K - Current report
2024/07/17

SEC問詢函

Form CORRESP - Correspondence
2024/07/17

SEC問詢函

Form CORRESP - Correspondence
2024/07/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]